Skip to content
The Skin Doctor

Doctor-led, evidence-based laser wart treatment at The Skin Doctor using a layered protocol of long-pulsed 1064 nm Nd:YAG, 2940 nm Er:YAG ablative laser and, in selected cases, laser-assisted photodynamic therapy (PDT). The strategy targets both the visible wart and the deeper viral drivers of recurrence — particularly valuable for plantar, periungual, mosaic and treatment-resistant warts.

Energy-based wart care

Laser Wart Treatment in Melbourne

Doctor-led, evidence-based laser wart treatment at The Skin Doctor using a layered protocol of long-pulsed 1064 nm Nd:YAG, 2940 nm Er:YAG ablative laser and, in selected cases, laser-assisted photodynamic therapy (PDT). The strategy targets both the visible wart and the deeper viral drivers of recurrence — particularly valuable for plantar, periungual, mosaic and treatment-resistant warts.

Portrait of Dr Christopher Irwin

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA

Last reviewed 2026-06-06 · Editorial policy

Quick definition

Laser wart treatment at The Skin Doctor is a layered, evidence-based protocol for stubborn, plantar, periungual and recurrent warts. Combines long-pulsed 1064 nm Nd:YAG (deep viral and vascular targeting), 2940 nm Er:YAG ablative laser (precise debulking), and — in selected recalcitrant cases — laser-assisted photodynamic therapy (PDT) to reduce recurrence. Doctor-led diagnosis is confirmed before any destructive treatment — atypical lesions go via biopsy or referral, not ablation. Particularly valuable for warts that have failed repeated cryotherapy or topical therapy.

Warts are caused by human papillomavirus (HPV) infection and can be painful, contagious, and frustratingly resistant to treatment. Plantar warts can interfere with walking; periungual warts are difficult to clear without damaging surrounding nail tissue; and many warts recur despite repeated freezing or topical therapies.

At The Skin Doctor, we provide doctor-led laser wart treatment using a layered, evidence-based strategy designed to target both the visible wart and the deeper viral drivers of recurrence. For selected patients, this may include a combination of Nd:YAG laser, Er:YAG ablative laser, and photodynamic therapy (PDT) — an approach increasingly supported by modern dermatology literature.

Why laser treatment for warts?

HPV-infected wart tissue often extends deeper than it appears clinically and is supported by a network of small blood vessels. Superficial treatments may remove surface keratin while leaving infected tissue behind.

Energy-based devices address these limitations by:

  • targeting virus-infected tissue directly
  • disrupting the blood supply that sustains the wart
  • reaching deeper wart components resistant to cryotherapy
  • reducing the need for repeated, painful treatments

A large 2024 systematic review of energy-based devices for cutaneous verrucae identified long-pulsed Nd:YAG and Er:YAG lasers as among the most studied and effective laser modalities, particularly for recalcitrant warts. (1)

Our layered treatment strategy

Not all warts require combination therapy. However, for thick, painful, long-standing, or recurrent warts, evidence increasingly supports a multi-step approach.

Step 1: Nd:YAG laser — deep viral and vascular targeting

The 1064 nm long-pulsed Nd:YAG laser penetrates deeply into hyperkeratotic wart tissue, targeting haemoglobin within the dilated capillaries that supply the wart. Histologic studies demonstrate coagulation of dermal vessels and destruction of infected tissue, with reduced residual HPV compared to cryotherapy. (1,2)

Clinical studies report clearance rates ranging from approximately 50–100% for palmoplantar and periungual warts, particularly in treatment-resistant cases. (1–3)

This step is especially useful for:

  • plantar (foot) warts
  • thick or painful pressure-bearing warts
  • mosaic or clustered warts
  • warts resistant to freezing or topical therapy

Step 2: Er:YAG ablative laser — precise debulking and clearance

The 2940 nm Er:YAG laser is strongly absorbed by water, allowing precise ablation of wart tissue with minimal thermal spread. Compared with older CO₂ lasers, Er:YAG is associated with reduced collateral damage and lower scarring risk.

A large 2024 retrospective analysis of 245 patients with recalcitrant warts treated with Er:YAG laser demonstrated a 71.6% complete resolution rate at 12 months, with better outcomes in non-smokers and non-periungual locations. (4) Earlier and contemporary studies consistently show clearance rates in the 70–90% range for selected wart types. (1,4,5)

Er:YAG ablation:

  • removes residual hyperkeratotic wart tissue
  • reduces viral load and mechanical pressure
  • improves access for adjunctive therapies

Step 3 (selected cases): photodynamic therapy (PDT) to reduce recurrence

For recalcitrant, multiple, or frequently recurring warts, laser treatment may be followed by photodynamic therapy (PDT).

The rationale is well supported in the literature:

  • laser debulking reduces the hyperkeratotic barrier
  • photosensitiser penetration is improved
  • PDT induces selective destruction of HPV-infected keratinocytes and may enhance local immune response

Studies combining Er:YAG laser with PDT have demonstrated higher clearance rates than PDT alone, including in difficult facial and plantar warts. (6) A 2024 systematic review also highlights PDT as a valuable adjunct in recalcitrant cases, with lower recurrence compared to cryotherapy in some studies. (1)

While no single protocol can guarantee eradication, the combination of Nd:YAG + Er:YAG followed by PDT is emerging as one of the most comprehensive strategies for destroying wart tissue and reducing recurrence risk in appropriately selected patients. (1,4,6,7)

Warts we commonly treat

  • plantar (foot) warts — particularly painful pressure-bearing and mosaic patterns
  • periungual and subungual warts — around and under the nails
  • mosaic or clustered warts
  • long-standing or recurrent warts
  • warts resistant to freezing or topical therapy

If a lesion is not clearly a wart, medical assessment is performed before any destructive treatment — atypical lesions are biopsied or referred rather than ablated.

What to expect

Downtime. Localised. Treated areas may blister or scab and typically heal over 1–2 weeks, depending on size and location.

Sessions. Some warts respond in 1–2 treatments. More resistant warts may require a staged plan with 3–4 sessions spaced 4–8 weeks apart, sometimes layered with PDT.

Comfort. Plantar and periungual warts can be uncomfortable to treat. Local anaesthetic and topical numbing are used where appropriate, and pain management options are discussed and tailored at the consultation.

Walking. After plantar treatment, most patients can walk — typically with some discomfort for 2–5 days. Cushioned footwear, an offloading pad and short-term reduction of high-impact activity help.

Book laser wart treatment

If you have a stubborn, painful, or recurrent wart and want a structured, evidence-based treatment plan, the booking panel in the sidebar takes you to the laser wart appointment.

You may also find these helpful:

References

  1. Le M, Conte S, Hsu JTS, Li MK. Energy-Based Devices for the Treatment of Cutaneous Verrucae: A Systematic Review. Dermatol Surg. 2024;50:345–353.
  2. Han TY, Lee JH, Lee CK, et al. Long-pulsed Nd:YAG laser treatment of warts: report on a series of 369 cases. J Korean Med Sci. 2009;24:889–893.
  3. Kimura U, Takeuchi K, Kinoshita A, et al. Long-pulsed 1064-nm Nd:YAG laser treatment for refractory warts on hands and feet. J Dermatol. 2014;41:252–257.
  4. Jiryis B, Avitan-Hersh E, Khamaysi Z. Erbium-YAG Laser Treatment for Recalcitrant Warts: A Retrospective Analysis. Dermatol Ther. 2024;2024:1890940.
  5. Wollina U, Konrad H, Karamfilov T. Treatment of common warts by Er:YAG laser. J Cutan Laser Ther. 2001;3:63–66.
  6. Song W, Zhang J, Gao N, et al. Combination of 2940-nm laser and photodynamic therapy for recalcitrant facial flat warts. Photodiagnosis Photodyn Ther. 2019;26:97–100.
  7. Jiryis B, Avitan-Hersh E, Khamaysi Z. Combined Er:YAG and long-pulsed Nd:YAG laser treatment for recalcitrant warts: a prospective randomized controlled trial. J Eur Acad Dermatol Venereol. 2023;37:2569–2574.

What to expect

  1. Doctor-led assessment

    Diagnosis is confirmed before any destructive treatment. Suspicious or atypical lesions are not treated as warts — they are managed via appropriate medical pathways (biopsy or referral) rather than ablated.

  2. Step 1 — long-pulsed Nd:YAG laser

    The 1064 nm Nd:YAG laser penetrates deeply into hyperkeratotic wart tissue, targeting haemoglobin within the dilated capillaries that supply the wart. Especially useful for plantar warts, thick or painful pressure-bearing warts, mosaic warts and warts resistant to freezing or topical therapy.

  3. Step 2 — Er:YAG ablative laser

    The 2940 nm Er:YAG laser is strongly absorbed by water, allowing precise ablation of wart tissue with minimal thermal spread. Used to remove residual hyperkeratotic wart tissue, reduce viral load and mechanical pressure, and improve access for adjunctive therapies.

  4. Step 3 (selected cases) — laser-assisted PDT

    For recalcitrant, multiple or frequently recurring warts, laser debulking may be followed by photodynamic therapy (PDT) to enhance photosensitiser penetration and induce selective destruction of HPV-infected keratinocytes.

  5. Aftercare and review

    Written wound-care instructions are provided. Sessions are spaced according to healing; many warts respond in 1–2 treatments, while resistant warts may require a staged plan with re-treatment at 4–8 week intervals.

Results timeline

  • Day of treatment Treated area is dressed; some pinpoint bleeding or early blistering is normal. Local anaesthetic wears off in 1–2 hours.
  • 1–2 weeks Local blistering or scabbing settles; treated tissue sloughs and the wart begins to clear.
  • 4–8 weeks Many warts respond within 1–2 sessions; more resistant warts are reviewed and re-treated as planned.
  • 3–6 months Final clearance assessed across the treatment course; combination strategies (Nd:YAG + Er:YAG ± PDT) typically completed by this point.
  • 12 months Published Er:YAG cohorts report approximately 71.6% complete resolution at 12 months in recalcitrant warts; combination strategies may further reduce recurrence.

Ideal candidate

  • Adults with plantar (foot), periungual or subungual warts
  • Patients with mosaic or clustered warts
  • Patients with long-standing or recurrent warts that have failed cryotherapy or topical therapy
  • Patients with thick, painful, pressure-bearing warts (especially on the soles) where walking is affected
  • Patients with multiple or widespread warts considering combination laser ± PDT protocols
  • Patients planning pregnancy who want warts cleared before some topical therapies become contraindicated
  • Patients considering surgical excision of a wart but wanting a less invasive option first
  • Patients prepared for a staged plan and appropriate downtime in selected combination cases

Frequently asked questions

  • Is laser better than freezing (cryotherapy) for stubborn warts?
    For deeper, plantar, periungual or recurrent warts, laser is often more effective than repeated freezing because it targets deeper infected tissue and the wart's blood supply, rather than only the surface keratin. A 2024 systematic review of energy-based devices for cutaneous verrucae identified long-pulsed Nd:YAG and Er:YAG as among the most studied and effective laser modalities — particularly in cases that have already failed multiple cryotherapy sessions. Simple, superficial common warts often still respond to cryotherapy or topical salicylic acid; laser is most useful when those have already been tried.
  • Will the wart come back?
    Recurrence is possible with any wart treatment — warts are caused by HPV, and the virus can persist in surrounding skin even after the visible wart is cleared. Evidence suggests combination strategies (Nd:YAG + Er:YAG, with PDT in selected recalcitrant cases) reduce recurrence risk compared with single-modality approaches. Recurrence is also lower in non-smokers and in non-periungual locations. We discuss realistic expectations and a follow-up plan at the consultation rather than promising eradication.
  • Are periungual and subungual warts harder to treat?
    Yes. Periungual (around-the-nail) and subungual (under-the-nail) warts are associated with lower clearance rates and often require more intensive or combination therapy. The nail unit makes both diagnosis and treatment delivery harder, and tissue thickness varies considerably. We typically use a staged plan with closer follow-up for these warts, and may use combination protocols earlier than for other sites.
  • Is laser wart treatment painful?
    Plantar and periungual warts can be uncomfortable to treat — these areas are sensitive and the laser energy has to penetrate hyperkeratotic tissue to reach the vascular supply. Local anaesthetic and topical numbing are used where appropriate, and pain management options are discussed and tailored at the consultation. Most patients tolerate sessions well; the brief discomfort is typically far less than living with a painful plantar wart long-term.
  • How many sessions will I need?
    Many warts respond in 1–2 sessions, particularly common warts and smaller plantar warts. More resistant warts — periungual, mosaic, long-standing, or those that have failed multiple prior treatments — often need 3–4 sessions spaced 4–8 weeks apart, and selected recalcitrant cases may benefit from layered protocols (Nd:YAG + Er:YAG ± PDT) over several months. Your specific course is mapped at the consultation based on wart location, size, thickness and treatment history.
  • Can I walk normally after plantar wart treatment?
    Most patients can walk — typically with some discomfort for 2–5 days, depending on size, location and how much debulking was performed. Cushioned footwear, an offloading pad and short-term reduction of high-impact activity (running, sport) help. Walking long distances or standing for prolonged periods may be uncomfortable in the first few days. We will give specific advice for your case before you leave the clinic.
  • Are warts contagious — and can they spread during treatment?
    Yes — warts are caused by HPV and can spread to other parts of the body (autoinoculation) and to other people through direct contact, shared surfaces, or shared towels / razors. Treatment does not increase contagion risk in any clinically meaningful way, but during the 1–2 week healing window the treated area is dressed and should be protected. We give specific aftercare advice (waterproof dressings, no shared towels, no swimming until healed) and discuss preventing recurrence elsewhere on the body.
  • Are laser wart treatments covered by Medicare?
    Generally not — laser wart removal at this clinic is a private fee-for-service treatment. There is no specific MBS item for laser wart treatment that reliably applies in this setting. We are transparent about costs at the consultation and provide a clear written quote for the planned course before treatment begins.

References

  1. Combined Er:YAG and long-pulsed Nd:YAG laser for recalcitrant warts — a prospective randomized controlled trial. J Eur Acad Dermatol Venereol. 2023.DOI: 10.1111/jdv.19388
  2. Pulsed dye laser versus Nd:YAG laser in the treatment of plantar warts — a comparative study. Lasers Med Sci. 2014.DOI: 10.1007/s10103-013-1479-y

Related

Related conditions

Related treatments

Medically reviewed by Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA · Last reviewed 2026-06-06 · Editorial policy